Hans Petter Eikesdal Selected Research

Hans Petter Eikesdal Research Topics

Disease

13	Neoplasms (Cancer) 04/2020 - 04/2002
11	Breast Neoplasms (Breast Cancer) 01/2022 - 08/2013
2	Neoplasm Metastasis (Metastasis) 05/2017 - 12/2016
2	Glioma (Gliomas) 03/2003 - 04/2002
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2018
1	Carcinogenesis 10/2018
1	Sarcoma (Soft Tissue Sarcoma) 07/2016
1	Ovarian Neoplasms (Ovarian Cancer) 01/2016
1	Carpal Tunnel Syndrome 08/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2013
1	Osteoporosis 08/2013
1	Arthralgia (Joint Pain) 08/2013
1	Overweight 08/2013
1	Pneumonia (Pneumonitis) 06/2013
1	Renal Cell Carcinoma (Grawitz Tumor) 09/2008
1	Hypoxia (Hypoxemia) 03/2003

Drug/Important Bio-Agent (IBA)

4	Angiogenesis InhibitorsIBA 01/2013 - 08/2004
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2014
2	Aromatase InhibitorsIBA 06/2020 - 08/2013
2	Hormones (Hormone)IBA 03/2019 - 01/2018
2	exemestane (Aromasin)FDA Link 03/2019 - 08/2013
2	Estrogen ReceptorsIBA 01/2018 - 08/2013
2	Biological ProductsIBA 01/2018 - 04/2014
2	Messenger RNA (mRNA)IBA 01/2018 - 05/2017
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 05/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 05/2017 - 12/2016
2	Epirubicin (Ellence)FDA LinkGeneric 05/2017 - 12/2016
2	Diphosphonates (Bisphosphonates)IBA 08/2014 - 08/2013
2	Pharmaceutical PreparationsIBA 08/2013 - 04/2002
1	Estradiol (Delestrogen)FDA LinkGeneric 06/2020
1	Estrone FDA Link 06/2020
1	Estrogens (Estrogen)FDA Link 06/2020
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2020
1	Everolimus FDA Link 03/2019
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 10/2018
1	Transforming Growth Factor-beta Type II ReceptorIBA 10/2018
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2018
1	3' Untranslated Regions (3' UTR)IBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 05/2017
1	Fluorouracil (Carac)FDA LinkGeneric 05/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2017
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 05/2017
1	Angiopoietin-2IBA 12/2016
1	CytokinesIBA 07/2016
1	Interleukin-6 (Interleukin 6)IBA 07/2016
1	tocilizumab (atlizumab)FDA Link 07/2016
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 07/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2016
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 04/2014
1	Insulin-Like PeptidesIBA 04/2014
1	Sirolimus (Rapamycin)FDA Link 04/2014
1	Phosphatidylinositols (Phosphatidylinositol)IBA 04/2014
1	Histone Deacetylases (Histone Deacetylase)IBA 04/2014
1	Epidermal Growth Factor (EGF)IBA 04/2014
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 08/2013
1	Anastrozole (Arimidex)FDA LinkGeneric 08/2013
1	Letrozole (Femara)FDA LinkGeneric 08/2013
1	Docetaxel (Taxotere)FDA Link 06/2013
1	Bevacizumab (Avastin)FDA Link 09/2008
1	type IV collagen alpha3 chain (Goodpasture antigen)IBA 09/2008
1	Integrin alphaVbeta3IBA 09/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2008
1	Peptides (Polypeptides)IBA 09/2008
1	Biological FactorsIBA 03/2003
1	4,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA 04/2002
1	fosbretabulin (combretastatin A4)IBA 04/2002
1	Vinblastine (Vinblastine Sulfate)FDA Link 04/2002

Therapy/Procedure

4	Therapeutics 06/2020 - 01/2013
3	Neoadjuvant Therapy 01/2022 - 05/2017
3	Drug Therapy (Chemotherapy) 12/2016 - 06/2013